Peddock Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Peddock Capital Advisors's BIIB Position: Q1 2020 in Review
Peddock Capital Advisors sold out of Biogen (BIIB) in Q1 2020, closing a stake of 151 shares — an estimated $45K sold.
Peddock Capital Advisors first reported a position in BIIB in Q1 2015 and held it in 18 quarters. The position peaked at $865K in Q3 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.
- Peddock Capital Advisors reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
- Peddock Capital Advisors sold 151 Biogen shares in Q1 2020, an estimated $45K.
- Peddock Capital Advisors first reported a position in Biogen in Q1 2015 and held it in 18 quarters.
- Peddock Capital Advisors's Biogen position peaked at $865K in Q3 2018.
- 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.
Based on Peddock Capital Advisors's 13F filing for Q1 2020, filed 13 May 2020.